These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
85 related articles for article (PubMed ID: 2896489)
1. Pharmacological evaluation of in vivo tests for alpha 2-adrenoceptor blockade in the central nervous system and the effects of the enantiomers of mianserin and its aza-analog ORG 3770. Gower AJ; Broekkamp CL; Rijk HW; Van Delft AM Arch Int Pharmacodyn Ther; 1988; 291():185-201. PubMed ID: 2896489 [TBL] [Abstract][Full Text] [Related]
2. alpha 2-Adrenoceptor agonists induced mydriasis in the rat by an action within the central nervous system. Berridge TL; Gadie B; Roach AG; Tulloch IF Br J Pharmacol; 1983 Mar; 78(3):507-15. PubMed ID: 6132641 [TBL] [Abstract][Full Text] [Related]
3. Napamezole, an alpha-2 adrenergic receptor antagonist and monoamine uptake inhibitor in vitro. Perrone MH; Hamel LT; Ferrari RA; Haubrich DR J Pharmacol Exp Ther; 1990 Aug; 254(2):471-5. PubMed ID: 1974637 [TBL] [Abstract][Full Text] [Related]
4. In vivo assessment of napamezole, an alpha-2 adrenoceptor antagonist and monoamine re-uptake inhibitor. Perrone MH; Luttinger D; Hamel LT; Fritz PM; Ferraino R; Haubrich DR J Pharmacol Exp Ther; 1990 Aug; 254(2):476-83. PubMed ID: 1974638 [TBL] [Abstract][Full Text] [Related]
5. Antagonism by mianserin and classical alpha-adrenoceptor blocking drugs of some cardiovascular and behavioral effects of clonidine. Robson RD; Antonaccio MJ; Saelens JK; Liebman J Eur J Pharmacol; 1978 Feb; 47(4):431-42. PubMed ID: 24544 [TBL] [Abstract][Full Text] [Related]
6. An in vivo model for investigating alpha 1- and alpha 2-receptors in the CNS: studies with mianserin. Clineschmidt BV; Flataker LM; Faison E; Holmes R Arch Int Pharmacodyn Ther; 1979 Nov; 242(1):59-76. PubMed ID: 44455 [TBL] [Abstract][Full Text] [Related]
7. Antagonistic effects of some metabolites and analogues of mianserin on serotonin and alpha 1- and alpha 2-adrenergic receptors in the flexor reflex model in vivo. Przegaliński E; Rawłów A; Dohnal-Borak I Pol J Pharmacol Pharm; 1986; 38(1):69-75. PubMed ID: 3020532 [TBL] [Abstract][Full Text] [Related]
8. The effects of alpha-2 agonists and antagonists on gastric acid secretion. Bernardini C; Del Tacca M; Soldani G; Martinotti E Arch Int Pharmacodyn Ther; 1986 May; 281(1):134-44. PubMed ID: 2875694 [TBL] [Abstract][Full Text] [Related]
9. Alpha 2-adrenoceptor-blocking properties of midaglizole (DG-5128) in rats. Hirohashi M; Tanaka M; Suzuki I; Akashi A Arch Int Pharmacodyn Ther; 1990; 306():75-86. PubMed ID: 1981668 [TBL] [Abstract][Full Text] [Related]
10. Sleeping times evoked by alpha adrenoceptor agonists in two-day-old chicks: an experimental model to evaluate full and partial agonists at central alpha-2 adrenoceptors. Roach AG; Doxey JC; Strachan DA; Cavero I J Pharmacol Exp Ther; 1983 Nov; 227(2):421-8. PubMed ID: 6138427 [TBL] [Abstract][Full Text] [Related]
11. Different alpha-adrenoreceptors in the central nervous system mediating biochemical and functional effects of clonidine and receptor blocking agents. Andén NE; Grabowska M; Strömbom U Naunyn Schmiedebergs Arch Pharmacol; 1976; 292(1):43-52. PubMed ID: 6918 [TBL] [Abstract][Full Text] [Related]
12. Antagonistic effects of S9871 or (imidazolinyl-2)-2-dihydro 2,3 benzofurane and its stereoisomers on some central and peripheral actions of alpha 2-agonists. Joly G; Mouillé P; Schmitt H Arch Int Pharmacodyn Ther; 1985 Oct; 277(2):180-91. PubMed ID: 2865936 [TBL] [Abstract][Full Text] [Related]
13. Effects of alpha-adrenoceptor antagonists on the mydriatic and bradycardic effects of detomidine. Hanson CE; Hsu WH Arch Int Pharmacodyn Ther; 1987 Jun; 287(2):291-8. PubMed ID: 2888443 [TBL] [Abstract][Full Text] [Related]
14. Pre- and postsynaptic a-adrenoceptor blockade by (imidazolinyl-2)-2-benzodioxane 1-4 (170 150): antagonistic action on the central effects of clonidine. Dabiré H; Mouillé P; Andréjak M; Fournier B; Schmitt H Arch Int Pharmacodyn Ther; 1981 Dec; 254(2):252-70. PubMed ID: 6121540 [TBL] [Abstract][Full Text] [Related]
15. Mianserin--an analysis of its peripheral autonomic actions. Doxey JC; Everitt J; Metcalf G Eur J Pharmacol; 1978 Sep; 51(1):1-10. PubMed ID: 29761 [TBL] [Abstract][Full Text] [Related]
16. Differences in modulation of noradrenergic and serotonergic transmission by the alpha-2 adrenoceptor antagonists, mirtazapine, mianserin and idazoxan. de Boer TH; Nefkens F; van Helvoirt A; van Delft AM J Pharmacol Exp Ther; 1996 May; 277(2):852-60. PubMed ID: 8627567 [TBL] [Abstract][Full Text] [Related]
17. Effects of central alpha-2 adrenergic compounds on canine narcolepsy, a disorder of rapid eye movement sleep. Nishino S; Haak L; Shepherd H; Guilleminault C; Sakai T; Dement WC; Mignot E J Pharmacol Exp Ther; 1990 Jun; 253(3):1145-52. PubMed ID: 1972749 [TBL] [Abstract][Full Text] [Related]
18. Simple behavioral measures of central alpha-adrenoceptor blocking activity of drugs. Delini-Stula A Pol J Pharmacol Pharm; 1984; 36(5):513-21. PubMed ID: 6152494 [TBL] [Abstract][Full Text] [Related]
19. A study of the selectivity and potency of rauwolscine, RX 781094 and RS 21361 as antagonists of alpha-1 and alpha-2 adrenoceptors. Timmermans PB; Qian JQ; Ruffolo RR; van Zwieten PA J Pharmacol Exp Ther; 1984 Mar; 228(3):739-48. PubMed ID: 6142941 [TBL] [Abstract][Full Text] [Related]
20. Antagonism of the drug induced behavioural sleep in chicks. Fügner A Arzneimittelforschung; 1971 Sep; 21(9):1350-2. PubMed ID: 5171790 [No Abstract] [Full Text] [Related] [Next] [New Search]